You may also like
Use of Recombinant Factor VIIa for Refractory Hemorrhage During Extracorporeal Membrane Oxygenation
To describe the outcome and treatment of two patients with recombinant factor VIIa (rFVIIa) for severe hemorrhage associated with extracorporeal membrane oxygenation (ECMO).
Coronary Bypass Safe in Patients With Low Ejection Fraction
SAN FRANCISCO (Reuters Health) – Patients with coronary artery disease and severely impaired left ventricular ejection fraction can still benefit from coronary […]
Production Standard and Stability of Compounded Del Nido Cardioplegia Solution
This report defines in-house production standards, as well as the stability of del Nido cardioplegia solution (dNCS) under optimal storage conditions.